Acute Asthma Exacerbation: Evaluation and Treatment

Conclusión

Initial workup

• Rapid bedside severity assessment: speech, accessory-muscle use, respiratory rate, heart rate, blood pressure, mental status, pulse oximetry, and peak expiratory flow (PEF) or FEV1 if feasible.
• Take a focused history in parallel with therapy: trigger, time course, prior intubations or ICU stays, recent corticosteroid use, controller adherence, comorbidities, and risk factors for asthma death.
• Obtain baseline labs or imaging only for severe cases or poor response: ABG/VBG, electrolytes (watch for beta-agonist–induced hypokalemia), and a chest radiograph for suspected pneumonia or pneumothorax.
• Classify severity (mild-moderate vs severe/life-threatening) to guide disposition and escalation.

Acute management

• Oxygen titrated to an SpO2 of 93–95% (avoid hyperoxia).
• Inhaled SABA: albuterol 4–10 puffs by MDI with spacer every 20 minutes for 3 doses (or continuous nebulization) during the first hour.
• Add ipratropium bromide with each SABA dose in moderate-to-severe attacks (e.g., a nebulized combination every 20 minutes for 3 doses).
• Start a systemic corticosteroid early: prednisolone or prednisone 40–50 mg PO (or methylprednisolone 60–80 mg IV); a typical course is 5–7 days.
• Reassess at 1 hour; continue SABA as needed every 1–4 hours based on response, correct fluid and electrolyte losses, and monitor potassium.
• For poor response: IV magnesium sulfate 2 g over 20 minutes; prepare for intubation if there is worsening fatigue, rising CO2, or altered mentation.

Inpatient and longitudinal management

• Optimize controller therapy before discharge — an appropriate ICS-containing regimen (e.g., low-dose ICS-formoterol as maintenance-and-reliever, or medium-dose ICS-LABA) per GINA step-up guidance.
• Review inhaler technique and adherence, and provide a written asthma action plan with peak-flow thresholds.
• Address triggers (allergens, smoking cessation, occupational exposures); consider ABPA screening for recurrent severe exacerbations.
• Ensure follow-up within 2 weeks of the exacerbation, then every 1–3 months.

Monitoring and disposition

• Continuous vitals, mental status, and SpO2 until stable; PEF or FEV1 every 20–60 minutes during the acute phase, then every 4 hours.
• Monitor electrolytes (potassium, magnesium) and glucose with repeated beta-agonists or systemic steroids.
• Discharge criteria: PEF ≥ 70% of predicted or personal best, minimal symptoms for ≥ 3–4 hours, SABA spacing ≥ 4 hours, stable vitals, a safe home environment, and a written plan with follow-up arranged.

Escalate care if

• PEF or FEV1 is < 40% predicted after the first hour, or there is persistent hypoxemia, a silent chest, drowsiness, or a rising PaCO2 — move to ICU and consider continuous nebulized beta-agonist, IV magnesium, ketamine, or early intubation.
• Hemodynamic instability or a need for mechanical ventilation — consult critical care and anesthesiology early.

Duration

Systemic steroids for 5–7 days; a taper is typically unnecessary for courses of 7 days or fewer.

Advertencias

• Use systemic steroids with caution in uncontrolled infection, diabetes complications, or a severe psychiatric history.
• Watch for hypokalemia and other electrolyte shifts with repeated beta-agonist dosing.

Referencias

1. Severe asthma guidelines. · Guía de práctica clínica
2. Guidelines for the Diagnosis and Management of Asthma (EPR-3). (2007) · Guía de práctica clínica“A patient presenting with a reported asthma exacerbation must be evaluated and triaged immediately, based on at least vital signs and an overall physical assessment (e.g., ability to breathe well enough to talk).”
3. Summary Guide for Asthma Management and Prevention. · Guía de práctica clínica“Short-term use for severe acute exacerbations: effective for preventing short-term recurrence of severe asthma exacerbations.”
4. Global strategy for asthma management and prevention (GINA). Eur Respir J. · Guía de práctica clínica
5. Summary Guide for Asthma Management and Prevention (2025). (2025) · Guía de práctica clínica
6. Guidelines for the Diagnosis and Management of Asthma 2007 (EPR-3). (2007) · Guía de práctica clínica“Ipratropium with albuterol nebulizer solution: 1.5–3.0 mL every 20 minutes for 3 doses, then as needed.”